Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

Peer Review reports

Original Submission
15 Dec 2019	Submitted	Original manuscript
27 Dec 2019	Author responded	Author comments - Olga Furashova
Resubmission - Version 2
27 Dec 2019	Submitted	Manuscript version 2
23 Jan 2020	Reviewed	Reviewer Report
31 Jan 2020	Reviewed	Reviewer Report
26 Mar 2020	Author responded	Author comments - Olga Furashova
Resubmission - Version 3
26 Mar 2020	Submitted	Manuscript version 3
8 Apr 2020	Reviewed	Reviewer Report
2 May 2020	Reviewed	Reviewer Report
24 Jun 2020	Author responded	Author comments - Olga Furashova
Resubmission - Version 4
24 Jun 2020	Submitted	Manuscript version 4
30 Jun 2020	Reviewed	Reviewer Report
9 Jul 2020	Reviewed	Reviewer Report
15 Jul 2020	Author responded	Author comments - Olga Furashova
Resubmission - Version 5
15 Jul 2020	Submitted	Manuscript version 5
Publishing
20 Jul 2020	Editorially accepted
29 Jul 2020	Article published	10.1186/s12886-020-01576-w

Back to article page